FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...